Working at Charité
We are seeking a motivated team member to support the implementation of the DZHK-funded XCVD cohort study starting January 1, 2027. The study is led by Prof. Sofia Forslund-Startceva (Forslund Lab, Experimental and Clinical Research Center, Charité – Universitätsmedizin Berlin & Max Delbrück Center). The study investigates how gender-affirming hormone therapy affects cardiovascular disease risk factors and explores the potential role of the gut microbiome in mediating these effects. A total of 200 transgender individuals will be recruited and followed as part of the cohort.
As part of the study, blood, stool, saliva, and skin samples will be collected to analyze hormone levels, metabolic and inflammatory markers, and the microbiome. In addition, data on body composition and lung function, as well as dietary habits, lifestyle, and psychosocial health, will be collected. Assessments will include well-being, gender dysphoria, stress, fatigue, depressive symptoms, physical activity, quality of life, and sleep.
The position is initially limited in duration, with the possibility of an extension based on suitability and mutual interest. An increase in working hours may also be possible in the future.
Information regarding the position
- Pay grade E9a TVöD VKA K. You can find all information about salary and the collective bargaining agreement here.
- The position is part-time, with 30 working hours per week.
- The position is fixed-term until December 31, 2027, as it is linked to the duration of the project.
- We offer 30 days of annual leave as standard.
- Application deadline: 05.11.2026
- Reference number: 8317